ATE553378T1 - Screening und behandlungsverfahren zur vorbeugung von frühgeburten - Google Patents
Screening und behandlungsverfahren zur vorbeugung von frühgeburtenInfo
- Publication number
- ATE553378T1 ATE553378T1 AT08005572T AT08005572T ATE553378T1 AT E553378 T1 ATE553378 T1 AT E553378T1 AT 08005572 T AT08005572 T AT 08005572T AT 08005572 T AT08005572 T AT 08005572T AT E553378 T1 ATE553378 T1 AT E553378T1
- Authority
- AT
- Austria
- Prior art keywords
- screening
- subject
- prevent premature
- treatment procedures
- premature birth
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- 238000012216 screening Methods 0.000 title abstract 2
- 208000005107 Premature Birth Diseases 0.000 title 1
- 206010036590 Premature baby Diseases 0.000 title 1
- 239000012530 fluid Substances 0.000 abstract 2
- PROQIPRRNZUXQM-UHFFFAOYSA-N (16alpha,17betaOH)-Estra-1,3,5(10)-triene-3,16,17-triol Natural products OC1=CC=C2C3CCC(C)(C(C(O)C4)O)C4C3CCC2=C1 PROQIPRRNZUXQM-UHFFFAOYSA-N 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 230000003111 delayed effect Effects 0.000 abstract 1
- PROQIPRRNZUXQM-ZXXIGWHRSA-N estriol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H]([C@H](O)C4)O)[C@@H]4[C@@H]3CCC2=C1 PROQIPRRNZUXQM-ZXXIGWHRSA-N 0.000 abstract 1
- 229960001348 estriol Drugs 0.000 abstract 1
- 239000003550 marker Substances 0.000 abstract 1
- 210000002381 plasma Anatomy 0.000 abstract 1
- 239000000583 progesterone congener Substances 0.000 abstract 1
- 210000003296 saliva Anatomy 0.000 abstract 1
- 210000002700 urine Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
- G01N33/743—Steroid hormones
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/36—Gynecology or obstetrics
- G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Endocrinology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Biotechnology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Reproductive Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US44628803P | 2003-02-06 | 2003-02-06 | |
| US46652603P | 2003-04-28 | 2003-04-28 | |
| US49070603P | 2003-07-28 | 2003-07-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE553378T1 true ATE553378T1 (de) | 2012-04-15 |
Family
ID=32872757
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT08005572T ATE553378T1 (de) | 2003-02-06 | 2004-02-06 | Screening und behandlungsverfahren zur vorbeugung von frühgeburten |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20040266025A1 (de) |
| EP (2) | EP1590668A2 (de) |
| AT (1) | ATE553378T1 (de) |
| CA (1) | CA2512989A1 (de) |
| WO (1) | WO2004071427A2 (de) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6394952B1 (en) | 1998-02-03 | 2002-05-28 | Adeza Biomedical Corporation | Point of care diagnostic systems |
| US20050191704A1 (en) * | 2004-03-01 | 2005-09-01 | Kimberly-Clark Worldwide, Inc. | Assay devices utilizing chemichromic dyes |
| AU2005280528B2 (en) | 2004-07-30 | 2010-12-23 | Adeza Biomedical Corporation | Oncofetal fibronectin as a marker for disease and other conditions and methods for detection of oncofetal fibronectin |
| US20080090759A1 (en) * | 2004-08-30 | 2008-04-17 | Robert Kokenyesi | Methods and kits for predicting risk for preterm labor |
| PL2083863T3 (pl) | 2006-10-03 | 2015-08-31 | Genzyme Corp | Przeciwciała przeciwko TGF-beta do stosowania w leczeniu niemowląt obarczonych ryzykiem rozwinięcia się dysplazji oskrzelowo-płucnej |
| WO2008070467A2 (en) * | 2006-12-01 | 2008-06-12 | Joseph Thomas Weishaar | Method for preventing chronic disease |
| US8828981B2 (en) | 2007-02-06 | 2014-09-09 | George Creasy | Progesterone for the treatment or prevention of spontaneous preterm birth |
| WO2010009514A1 (en) * | 2008-07-25 | 2010-01-28 | Newcastle Innovation Limited | Methods and kits for predicting the onset of labour |
| GB0905964D0 (en) * | 2009-04-06 | 2009-05-20 | King S College London | Marker |
| FI123297B (fi) * | 2009-05-04 | 2013-02-15 | Valtion Teknillinen | Lateraalivirtausmäärityksen testiliuska ja sen valmistusmenetelmä |
| EP2544707B1 (de) * | 2010-03-09 | 2018-11-21 | Dignity Health | Verfahren zur unterdrückung von frühgeburtschmerzen und gebärmutterkontraktionsstörungen sowie zur verhinderung von gebärmutterreizungen |
| FR2960974B1 (fr) * | 2010-06-03 | 2016-12-30 | Biosynex | Procede de detection de rupture de membranes |
| US9375437B2 (en) | 2010-06-18 | 2016-06-28 | Lipocine Inc. | Progesterone containing oral dosage forms and kits |
| WO2012021944A1 (en) * | 2010-08-20 | 2012-02-23 | Newcastle Innovation Ltd | Methods and kits for predicting the onset of labour |
| US8765487B2 (en) * | 2010-09-01 | 2014-07-01 | Clinical Innovations | Detection of amniotic fluid in vaginal secretions of pregnant women due to premature rupture of fetal membranes |
| US11555816B2 (en) | 2010-09-01 | 2023-01-17 | Clinical Innovations, Llc | Detection of amniotic fluid in vaginal secretions of pregnant women due to premature rupture of fetal membranes |
| US10338065B2 (en) * | 2010-09-01 | 2019-07-02 | Clinical Innovations, Llc | Detection of amniotic fluid in vaginal secretions of pregnant women due to premature rupture of fetal membranes |
| KR101888213B1 (ko) * | 2010-10-01 | 2018-08-13 | 홀로직, 인크. | 진단 시스템에 사용하기 위한 면역분석 시험 스트립 |
| US9271991B2 (en) | 2010-10-27 | 2016-03-01 | Dignity Health | Trimegestone (TMG) for treatment of preterm birth |
| US8951996B2 (en) | 2011-07-28 | 2015-02-10 | Lipocine Inc. | 17-hydroxyprogesterone ester-containing oral compositions and related methods |
| CA2847257A1 (en) | 2011-09-16 | 2013-03-21 | University Of Louisville Research Foundation, Inc. | Methods of predicting and decreasing the risk of pre-term birth |
| WO2014066568A1 (en) | 2012-10-24 | 2014-05-01 | Winthrop-University Hospital | Non-invasive biomarker to identify subjects at risk of preterm delivery |
| EP3180611B1 (de) | 2014-08-12 | 2025-04-09 | NextGen Jane, Inc. | System und verfahren zur überwachung der gesundheit auf basis von gesammelter körperflüssigkeit |
| MX2017016823A (es) * | 2015-06-22 | 2018-03-12 | Lipocine Inc | Composiciones orales que contienen éster de 17- hydroxiprogesterona y métodos relacionados. |
| US9903866B2 (en) * | 2016-04-05 | 2018-02-27 | Conquerab Inc. | Portable devices for detection of antibodies against therapeutic drugs |
| WO2017180909A1 (en) | 2016-04-13 | 2017-10-19 | Nextgen Jane, Inc. | Sample collection and preservation devices, systems and methods |
| EP3682250A4 (de) | 2017-09-13 | 2021-03-03 | Progenity, Inc. | Präeklampsie-biomarker sowie zugehörige systeme und verfahren |
| WO2019152657A1 (en) * | 2018-02-03 | 2019-08-08 | Simple Healthkit, Inc. | Reliable, comprehensive, and rapid sexual health assessment |
| JP2022548314A (ja) * | 2019-09-23 | 2022-11-17 | ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー | 妊娠を遷延させるためおよび月経または妊娠の合併症の処置の方法 |
| EP4070113A4 (de) | 2019-12-04 | 2023-12-20 | Biora Therapeutics, Inc. | Beurteilung von präeklampsie unter verwendung von tests für freien und dissoziierten plazentalen wachstumsfaktor |
| CN113616660A (zh) * | 2020-05-07 | 2021-11-09 | 深圳埃格林医药有限公司 | 孕激素制剂及其用途 |
| US12426782B2 (en) | 2020-11-06 | 2025-09-30 | The Board Of Trustees Of The Leland Stanford Junior University | Systems and temporal alignment methods for evaluation of gestational age and time to delivery |
| CN115093475A (zh) * | 2022-07-08 | 2022-09-23 | 安徽惠邦生物工程有限公司 | 阴道分泌物胰岛素样生长因子结合蛋白-1提取液及其制备方法 |
| CN115144598B (zh) * | 2022-09-02 | 2023-03-10 | 山东子峰生物技术有限公司 | 一种胎儿纤维结合蛋白和胰岛素生长因子结合蛋白-1的量子点荧光检测方法及应用 |
| CN120787316A (zh) * | 2022-10-21 | 2025-10-14 | 科瑞生物股份有限公司 | 具有羊水标志物检测试纸条的穿戴物品 |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4894326A (en) | 1986-04-09 | 1990-01-16 | Fred Hutchinson Cancer Research Center | Monoclonal antibody defining oncofetal structure of fibronectin |
| US5132097A (en) | 1987-02-11 | 1992-07-21 | G.D. Research | Apparatus for analysis of specific binding complexes |
| CA1303983C (en) | 1987-03-27 | 1992-06-23 | Robert W. Rosenstein | Solid phase assay |
| US5223440A (en) | 1987-11-17 | 1993-06-29 | Adeza Biomedical Corporation | Ex vivo product of conception test to determine abortion |
| US5185270A (en) | 1987-11-17 | 1993-02-09 | Adeza Biomedical Corporation | Fetal fibronectin pregnancy test |
| US5096830A (en) | 1987-11-17 | 1992-03-17 | Adeza Biomedical Corporation | Preterm labor and membrane rupture test |
| US4919889A (en) | 1988-09-15 | 1990-04-24 | Aspen Diagnostics Corporation | Sample collection and transport fluid composition |
| US5079171A (en) | 1988-09-15 | 1992-01-07 | Adeza Biomedical Corporation | Determining pregnancy induced hypertension and eclampsia by immunoassay of cellular fibronectin |
| US5281522A (en) | 1988-09-15 | 1994-01-25 | Adeza Biomedical Corporation | Reagents and kits for determination of fetal fibronectin in a vaginal sample |
| US5252459A (en) | 1988-09-23 | 1993-10-12 | Abbott Laboratories | Indicator reagents, diagnostic assays and test kits employing organic polymer latex particles |
| US5236846A (en) | 1988-11-18 | 1993-08-17 | Adeza Biomedical Corporation | Ectopic pregnancy test |
| US5211952A (en) | 1991-04-12 | 1993-05-18 | University Of Southern California | Contraceptive methods and formulations for use therein |
| WO1993009432A1 (en) | 1991-11-04 | 1993-05-13 | Adeza Biomedical Corporation | Screening method for identifying women at increased risk for imminent delivery |
| US5516702A (en) | 1991-11-06 | 1996-05-14 | Adeza Biomedical Corporation | Screening method for identifying women at increased risk for imminent delivery |
| AU5142193A (en) | 1992-09-28 | 1994-04-26 | Biex, Inc. | Method for prediction of premature labor |
| JP3742649B2 (ja) | 1993-01-22 | 2006-02-08 | アデザ・バイオメデイカル・コーポレイシヨン | 切迫分娩についての危険にある女性における膜の破裂を決定するための検定方法 |
| US5500375A (en) | 1993-04-13 | 1996-03-19 | Serex, Inc. | Integrated packaging-holder device for immunochromatographic assays in flow-through or dipstick formats |
| US5370135A (en) | 1993-10-13 | 1994-12-06 | Biex, Inc. | Use of estriol measurement to monitor tocolytic therapy |
| US5650394A (en) * | 1993-11-04 | 1997-07-22 | Adeza Biomedical | Use of urinastatin-like compounds to prevent premature delivery |
| US5597700A (en) | 1994-04-28 | 1997-01-28 | California Research, Llc | Method for detecting free insulin-like growth-factor-binding protein 1 and a test device for detecting the ruptures of fetal membranes using the above method |
| US5658801A (en) | 1994-05-03 | 1997-08-19 | Spectral Diagnostics Inc. | Medical test kit |
| US5786227A (en) | 1995-06-07 | 1998-07-28 | Biex, Inc. | Fluid collection kit and method |
| US5656502A (en) | 1995-06-07 | 1997-08-12 | Diagnostic Chemicals Limited | Test strip holder and method of use |
| US5786228A (en) | 1995-06-07 | 1998-07-28 | Biex, Inc. | Fluid collection kit and method |
| US6267722B1 (en) | 1998-02-03 | 2001-07-31 | Adeza Biomedical Corporation | Point of care diagnostic systems |
| US6394952B1 (en) | 1998-02-03 | 2002-05-28 | Adeza Biomedical Corporation | Point of care diagnostic systems |
| US6375970B1 (en) * | 1999-07-07 | 2002-04-23 | Andre Bieniarz | Methods and materials for preterm birth prevention |
| FR2813840B1 (fr) | 2000-09-13 | 2003-04-04 | Bosch Gmbh Robert | Servofrein |
-
2004
- 2004-02-06 EP EP04709003A patent/EP1590668A2/de not_active Ceased
- 2004-02-06 AT AT08005572T patent/ATE553378T1/de active
- 2004-02-06 EP EP08005572A patent/EP1936376B1/de not_active Expired - Lifetime
- 2004-02-06 WO PCT/US2004/003428 patent/WO2004071427A2/en not_active Ceased
- 2004-02-06 US US10/774,144 patent/US20040266025A1/en not_active Abandoned
- 2004-02-06 CA CA002512989A patent/CA2512989A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP1936376B1 (de) | 2012-04-11 |
| EP1936376A2 (de) | 2008-06-25 |
| EP1936376A3 (de) | 2009-04-01 |
| EP1590668A2 (de) | 2005-11-02 |
| WO2004071427A2 (en) | 2004-08-26 |
| WO2004071427A3 (en) | 2005-04-14 |
| CA2512989A1 (en) | 2004-08-26 |
| US20040266025A1 (en) | 2004-12-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE553378T1 (de) | Screening und behandlungsverfahren zur vorbeugung von frühgeburten | |
| EA200801071A1 (ru) | Способы и композиции для применения в целях лечения пациентов с положительным по аутоантителам заболеванием | |
| TR200101769T2 (tr) | Biyolojik maddelerin uygulanmasını kolaylaştıran cihazlar ve işlemler. | |
| EA200801698A1 (ru) | Лекарственные композиции для применения в вагине | |
| Pryor et al. | Delayed timing of intrauterine insemination results in a significantly improved pregnancy rate in female partners of quadriplegic men | |
| BRPI0407213A (pt) | Método de emprego da elevação de marinobufagenina na determinação da presença de pré-eclampsia e aparelhos relacionados | |
| Sanoulis et al. | The use of plateletrich plasma in the gynaecological clinical setting. A review | |
| Al-Benna et al. | Postablative reconstruction is better terminology than oncoplastic surgery | |
| US20040059190A1 (en) | Method of colpoplasty | |
| EP1804789A4 (de) | Verfahren zur behandlung von präeklampsie beim menschen mit resibufagenin | |
| Muhajir et al. | Correlation between swelling post odontectomy in lower third molar with the increase of concentration alpha amylase saliva | |
| Koller et al. | Abdominoplasty flap elevation more superficially | |
| Bowers | Aesthetic male‐to‐female transsexual surgery | |
| BROWN | Osteomyelitis of the frontal bone | |
| Nawaz et al. | Outcome of Fast Track Surgery (FTS) or Enhanced Recovery after Surgery (ERAS) in Major Gynecological Surgeries | |
| RU2281748C2 (ru) | Способ коррекции гормональных и иммунных нарушений у больных гормонально зависимыми заболеваниями | |
| Farage et al. | The vulva | |
| Cantarella et al. | Simultaneous Sarles and transverse perineal support operation for the treatment of occult rectal prolapse, rectocele and perineal descent in patients with obstructed defecation syndrome | |
| Çeltik et al. | Health-related quality of life in patients undergoing surgery for upper extremity bone tumors: A cross-sectional study | |
| MD3222G2 (ro) | Metodă de diagnostic al cancerului endometrial | |
| Low | F Diagnostic US provides critical information in the evalu-ation. The ATA identifies size criteria and sonographic features of nodules that allow risk stratification. | |
| Radionov et al. | Crypto-glandular fistulous paraproctites-is the surgical prophylaxis of reccurences imperative? | |
| Savage et al. | Microbiological investigation of the mandibular condyle in patients with advanced osteoarthritis of the temporomandibular joint | |
| RU2412724C1 (ru) | Способ лечения воспалительного очага | |
| Makhlouf | Brachioplasty incision |